logo
welcome
Reuters

Reuters

Exclusive-CVS to exit core infusions services business, job cuts possible

Reuters
Summary
Nutrition label

81% Informative

CVS Health is exiting its core infusion services business and plans to either close or sell 29 related regional pharmacies.

Details of the strategic shift were announced in a CVS corporate memo dated Oct. 8 and seen by Reuters .

CVS bought Coram LLC , a drug infusion services provider, for $2.1 billion in 2013 .

VR Score

90

Informative language

94

Neutral language

83

Article tone

formal

Language

English

Language complexity

64

Offensive language

not offensive

Hate speech

not hateful

Attention-grabbing headline

not detected

Known propaganda techniques

not detected

Time-value

short-lived

External references

no external sources

Source diversity

no sources

Affiliate links

no affiliate links